Yahoo
Tokyo - Delayed Quote JPY

Koa Shoji Holdings Co.,Ltd. (9273.T)

847.00 +8.00 (+0.95%)
At close: 3:30:00 PM GMT+9
Chart Range Bar
Loading chart for 9273.T
  • Previous Close 839.00
  • Open 839.00
  • Bid 847.00 x --
  • Ask 848.00 x --
  • Day's Range 835.00 - 848.00
  • 52 Week Range 737.00 - 919.00
  • Volume 42,000
  • Avg. Volume 66,766
  • Market Cap (intraday) 35.674B
  • Beta (5Y Monthly) 0.54
  • PE Ratio (TTM) 9.52
  • EPS (TTM) 89.00
  • Earnings Date (est.) --
  • Forward Dividend & Yield 18.00 (2.15%)
  • Ex-Dividend Date Jun 29, 2027
  • 1y Target Est --

Koa Shoji Holdings Co.,Ltd., through its subsidiaries, imports and sells active pharmaceutical ingredients (APIs) in Japan. It operates through Active Pharmaceutical Ingredient Sales Business and Pharmaceutical Manufacturing and Sales Business segments. The company is involved in the manufacture and sale of over-the-counter drugs and pharmacologically active injection. It also engages in contract manufacturing of pharmaceuticals; and purchase and sale of pharmaceuticals. Koa Shoji Holdings Co.,Ltd. was founded in 1991 and is headquartered in Yokohama, Japan.

www.koashoji-hd.com

318

Full Time Employees

June 30

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/2/2026, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .

YTD Return

9273.T
2.19%
Nikkei 225 (^N225)
25.31%

1-Year Return

9273.T
10.95%
Nikkei 225 (^N225)
20.36%

3-Year Return

9273.T
23.83%
Nikkei 225 (^N225)
97.44%

5-Year Return

9273.T
31.13%
Nikkei 225 (^N225)
113.69%

Earnings Trends

View More

Earnings Per Share (GAAP)

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY26
Revenue 5.68B
Earnings 967M
Profit Margin 17.02%

Q1

FY25

Q3

FY25

Q1

FY26

Q3

FY26

0
2B
4B
15.0%
15.5%
16.0%
16.5%
17.0%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    15.19%

  • Return on Assets (ttm)

    9.05%

  • Return on Equity (ttm)

    12.64%

  • Revenue (ttm)

    24.68B

  • Net Income Avi to Common (ttm)

    3.75B

  • Diluted EPS (ttm)

    89.00

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    17.58B

  • Total Debt/Equity (mrq)

    10.65%

  • Levered Free Cash Flow (ttm)

    3.65B

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: